Keywords: dragon, gets, approval, epo, ecuador, canada, pharmaceuticals

Dragon gets approval for EPO in Ecuador

Article | 26 July 2004

Canada's Dragon Pharmaceuticals' recombinant erythropoietin product hasbeen granted access to Ecuador's market by its Ministry of Public Health, marking the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing